會員登入
註冊
GlobalBio & Investment
Go Global and Beyond:
A Premier Biomedical Media in Taiwan
A Premier Biomedical Media in Taiwan
DAY 1 Reports of BIO Asia-Taiwan 2024
2024-07-24 / GlobalBio & Investment
ThefirstdayofBIOAsia–Taiwan2024hascametotheend.Thanksforallparticipantstojointhiswonderfuleventdespitetheweather.Forallourreaders,weareexcitedtoofferourlatestreportsoftheopeningandthethreeplenar...
BIO Asia–Taiwan starts today!
2024-07-24 / GlobalBio & Investment
BIOAsia–Taiwan亞洲生技大會startstoday!PleasefollowusandstaytunedtoourspecialreportsofBIO-AsiaTaiwan2024.Theconferencethemethisyearis"GlobalView,AsianTouch".Manyspecialguestsfromabroadcametot...
Lukas Biomedical has signed a strategic cooperation agreement with Korea's GC Cell
2024-07-22 / GlobalBio & Investment
GoodnewsofcelltherapiesinTaiwan!Today,LukasBiomedical(#路迦生醫)fromTaiwan,hassignedastrategiccooperationagreementwithKorea'sGCCelltodevelopandexpandthemarketforimmunecelltherapies.https://lnkd.in/gyd...
Forum addressing "How to become an interdisciplinary biomedical talent"
2024-07-19 / GlobalBio & Investment
Thisafternoon,TiBIA(TaiwanBiomedicalInnovationAssociation)andGlobalBio&InvestmentMonthlyheldaforumaddressing"howtobecomeaninterdisciplinarybiomedicaltalent",andinvitedthreerepresentative...
Join Us at the BIO Asia-Taiwan 2024!
2024-07-19 / GlobalBio & Investment
JoinUsattheBIOAsia-Taiwan2024!KickingoffnextWednesday,July24th,2024,theBIOAsia–TaiwanInternationalConferenceandExhibitionisbackforitssixthyear,bringingtogetherbiotechleadersfromTaiwan,theUS,Japa...
The seminar about organoids and organ-on-chips on new drug development
2024-07-18 / GlobalBio & Investment
Lastweek,wehadthehonortoholdaseminarwithNationalBiotechnologyResearchPark,BiomedicalTranslationResearchCenter,andMolecularDevices,toexplorethepotentials,futuretrendsandrevolutionoforganoidsandorgan-on...
Medical Taiwan 2024 Wraps Up with Record-Breaking Attendance
2024-07-17 / GlobalBio & Investment
MedicalTaiwan2024WrapsUpwithRecord-BreakingAttendance!MedicalTaiwan2024wrappeduponJune21,attractingover8,000visitors,a10%increasefromlastyear,withnearly1,000internationalattendeesfromJapan,Thailand,Ko...
List of 11 biopharma companies making headway to global markets
2024-07-16 / GlobalBio & Investment
During2024H1,biopharmacompaniesinTaiwanreceivedalotofgoodnewsinclinical,developmental,approvalandlicensingprogress.Inthisarticle,wesummarizedalistof11biopharmacompaniesmakingheadwaytoglobalmarkets.Let...
Biotech leaders from Taiwan, the US, Japan, and beyond to explore global business opportunities!
2024-07-16 / GlobalBio & Investment
KickingoffnextWednesday,July24th,2024,theBIOAsia-TaiwanInternationalConferenceandExhibitionisbackforitssixthyear,bringingtogetherbiotechleadersfromTaiwan,theUS,Japan,andbeyondtoexploreglobalbusinessop...
Medical Taiwan Visitors Grow 10% Year-on-year; Japan, Korea, and SE Asia Actively Participate
2024-07-16 / GlobalBio & Investment
MedicalTaiwan2024,athree-dayexhibition,wrappeduponJune21.Thisyear’sexhibitionissaidtobethelargestinitshistory,attractingover8,000visitorsoverthethree-dayexhibition,a10%increasefrom2023,andwithne...
圖爾思成立儀器部門以因應市場需求
2024-07-16 / GlobalBio & Investment
圖爾思生物科技股份有限公司儀器部門，致力於提供先進的生命科學儀器和設備，以支持各種生物科技研究和臨床應用。秉持著成為生技產業最佳合作夥伴與上游供應商，我們專注於引進和代理世界領先的科學儀器，目前代理了BeckmanCoulter、Cytiva、Leica等各大品牌，並提供全面的技術支持與服務，幫助科研人員實現高效、精確的實驗結果本次參展四大主題：從研究到生產，助力微生物產業的高效轉型加速生物製藥開...
新穎生醫啟動技術授權 爭取DNlite-IVD103納入預防指引
2024-07-16 / GlobalBio & Investment
新穎生醫DNlite-IVD103，是全球第一個應用於精準管理與預防糖尿病腎病變(DKD)腎功能快速惡化的檢測試劑，透過檢測尿液中特定生物標記的變化，可有效預測與監控患者未來5年腎功能的惡化狀況，達到疾病的精準照護與管理。DNlite-IVD103已取得歐盟多國、臺灣、馬來西亞、泰國、越南、印尼、沙烏地阿拉伯、阿拉伯聯合大公國等批准上市，適應症包括糖尿病腎病變(DKD)檢測、以及腎移植監控等，今年...
